Da Costa International Funds for Breast Cancer Prevention
The California Pacific Medical Center Research Institute
Steven R. Cummings, M.D., FACP
Steven R. Cummings, M.D., FACP is the Director of Clinical Research at California Pacific Medical Center and a Professor of Epidemiology & Biostatistics at the University of California, San Francisco. He directs the San Francisco Coordinating Center, which conducts studies on osteoporotic fractures and women’s health.
Dr. Cummings completed his residency in Internal Medicine, and Fellowship in Clinical Epidemiology at the University of California, San Francisco and served as Chief of General Internal Medicine, and Associate Chair of Medicine for Clinical Research. He co-founded the Postgraduate Clinical Research Training Program at the University of California, San Francisco over 20 years ago and is co-author of the textbook “Designing Clinical Research.” Dr. Cummings leads the NIH-funded Study of Osteoporotic Fractures and several other NIH-funded studies. He led the Multiple Outcomes of Raloxifene (MORE) trial, which was the first study to show that a “designer estrogen” reduced risk of fractures and breast cancer, and the Fracture Intervention Trial (FIT), the first to show that a drug treatment reduced hip fracture risk. He currently chairs the Steering Committee of the PEARL trial of a new SERM for osteoporosis and the LIFT trial of tibolone for osteoporosis.
Publications by Steve R Cummings, M.D. in PubMed.